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Editors’ note: In this installment of Implementation
Science Workshop, Dr. Hagedorn and colleagues de-
scribe implementation and evaluation of a liver health
training program at the Minneapolis VA. In an accom-
panying commentary, Bruce Landon, MD, MBA, MSc,
of Harvard Medical School highlights the distinction
between evaluating the process and effectiveness of an




Drug- and alcohol-dependent individuals are at a much higher
risk for hepatitis infections than the general population and are at
higher risk of poor outcomes following infection.1–13 Because of
these risk factors, substance use disorder treatment clinics rep-
resent an ideal venue for screening, education, prevention, and
treatment referral services for patients with hepatitis infections.
The Liver Health Initiative (LHI) was a training program
jointly sponsored by the Veterans Health Administration’s
(VA) Substance Use Disorders Quality Enhancement Re-
search Initiative (SUDQUERI) and the Minneapolis VA Hep-
atitis C Resource Center (HCRC), with the goal of
implementing these services in VA SUD clinics. The program
was based on a successful liver health program established in
the Minneapolis VA Health Care System’s Addictive Disor-
ders Service14 and a training model previously used by the
HCRC to promote evidence-based evaluation and treatment of
patients with hepatitis C.15 The program design was informed
by empirically based literature on the education of medical
providers and the dissemination of health care innovations.16–
22
The purpose of this paper is to describe the LHI training
model, which shows promise for promoting implementation
of hepatitis services in SUD clinics and may also be general-
izable to promoting implementation of other evidence-based
health care practices. The evaluation of this initial cohort of
LHI trainees builds on the previous evaluation by assessing
the generalizability of the effectiveness of this training pro-
gram to a new topic area and target audience, comparing the
intervention teams to wait-list teams receiving informational
materials only, and collecting qualitative data regarding bar-
riers, facilitators and strategies utilized to provide information
about team or organizational characteristics that affect change.
We hypothesized that 1) the training program would be effec-
tive in promoting implementation of recommended practices,
2) teams attending the training program would demonstrate
greater success with implementation compared to wait-listed
teams, and 3) the degree of implementation success would
vary among teams attending the training, with qualitative data
providing exploratory information on potential team and or-




Teams from VA SUD clinics volunteered to participate in the
LHI training program in response to advertisements on the VA
national addictions email group and conference calls. Teams
were randomly assigned either to participate in the training
program or to be placed on a waiting list and provided with
printed educational materials. A representative from each
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training team andwait-listed teamwas interviewed at 1, 3, and 6
months post-intervention on self-reported implementation suc-
cess as well as implementation strategies, barriers, and facilita-
tors. This study was reviewed and approved by theMinneapolis
VA Health Care System’s institutional review board.
Participants
Applicants were required to apply as a team including a
representative of SUD or mental health service leadership, a
front-line SUD provider with an interest in providing liver
health services, and a hepatitis clinician. Applicants from 25
VA medical centers across the United States applied to partic-
ipate. Of the 17 facilities that applied with a full team, 11 were
randomly selected to participate in the training program. The
remaining six teamswere informed that theywere on a waiting
list for the next training program and were sent a training
binder containing all materials distributed at the training. All
wait-listed teams were asked to complete study evaluations,
and five of six agreed. All training and wait-listed teams were
located within large medical centers in urban areas. Online
Appendix 1 presents the clinic roles of teammembers, number
of patients served and staffing levels of the SUD clinics, and
location and complexity of the medical facilities in which the
SUD clinics were located. All VHA facilities receive a com-
plexity rating based on the clinical services offered, character-
istics of the patient population served, and educational and
research mission, with 1A representing the most complex
medical facilities and 3 representing the least complex. (See
Online Appendix 2 for details on complexity rating
methodology.)
PROGRAM DESCRIPTION
Both training and wait-list teams were sent a Needs Assess-
ment Questionnaire 6 weeks prior to the 1.5-day training (see
Online Appendix 3). The questionnaire was designed to eval-
uate current clinic practices regarding the five implementation
goals listed in Table 1. As shown in Table 1, the teams had one
or more goals in place at baseline. However, most teams had
several, and all had at least one implementation goal that they
could work on. Needs Assessment information was utilized
during the Action Planning phase of the 1.5-day training to
assist the training teams in developing concrete implementa-
tion goals that would address gaps between baseline and
recommended practice. Teams were strongly encouraged, but
not required, to address all unmet goals in their Action Plan.
The first day of the training consisted of didactic presenta-
tions and discussion periods covering the risks for liver disease
among patients with SUDs, the goals of the LHI, and imple-
mentation strategies. The second day was devoted to assisting
teams in developing site-specific action plans. Each team was
presented with an Action Plan formwith implementation goals
and Needs Assessment information regarding the baseline
practice that they had recorded. Teams were encouraged to list
an improvement goal and specific actions that they could
commit to within the next month for each row in which the
baseline practice did not match the implementation goal.
As part of the training intervention, one representative from
each training team was contacted by phone 1, 3, and 6 months
after the training. The representative was required to be an
SUD clinic staff member with close knowledge of daily pro-
cesses within the clinic, and was generally the SUD clinic
coordinator or an SUD nurse. The purpose of these coaching
calls was to assess progress on Improvement Goals and Action




Semi-structured interview follow-up assessments were com-
pleted at 1, 3, and 6 months post-training for both the training
and comparison teams. At each assessment, teams were eval-
uated on whether they had achieved each of the implementation
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goals that had not already been fully in place at baseline. The
designated team representative reported on current clinic prac-
tices. Table 1 describes the practices that were required to be in
place to receive Bcredit^ for the implementation of each goal.
Implementation success was determined by the number of
implementation goals achieved by the 6-month follow-up as-
sessment. Teams only received Bcredit^ for achieving imple-
mentation goals that had not already been in place at baseline.
Because teams had different numbers of services in place at
baseline, consideration was given to counting all services in
place. However, because the focus of the training was on
implementing new practices, it was ultimately decided that this
would better reflect the impact of the program. Only two teams
had more than two services in place at baseline, so most teams
had the opportunity to demonstrate a high degree of change.
Implementation strategies used (e.g., actions taken by team
members to implement goals) were assessed based on re-
sponses to open-ended interview questions. Respondents were
also asked to report on perceived local barriers and facilitators
with regard to the changes they were attempting to implement
(e.g., what helped or hindered their implementation efforts).
Researchers analyzed responses using a standard qualitative
analysis technique that consisted of creating a code list with
categories of major themes and coding text into the major
categories.23 Coders (HH & NR), who were blind to site,
condition, implementation success, and time point (1-, 3-, or
6-month follow-up), collaboratively created a list of codes
within the broad categories of strategies, barriers, and facilita-
tors, as well as additional codes as relevant from the interviews.
The two original coders plus a third coder then held coding
meetings in which they reviewed their independently created
codes and resolved any inconsistencies collaboratively. Once
all documents were coded and inconsistencies were resolved,
coders were un-blinded to team condition and implementation
success for data analysis. Clinics were grouped according to
high, moderate, low, or no change, and strategies, barriers, and
facilitators reported by the teams were examined to assess for
differences in type and frequency of codes reported.
Results
The results indicated that teams fell into four distinct groups:
1) those that had few services in place at baseline and imple-
mented three to five recommendations (high), 2) those that had
some services in place at baseline and implemented two addi-
tional services (moderate), 3) those that added one new service
(low), and 4) those that did not implement any practice change
(none). Results showed that the training was effective in
promoting implementation of recommended practices, with
nine of 11 intervention teams (82 %) achieving high to mod-
erate implementation success. The results also confirmed that
the training was more effective than receiving printed mate-
rials, with all wait-listed teams falling into the low or no
change categories. Categorizing by total services in place
rather than new services implemented would have resulted in
one intervention team and one wait-list team being rated more
highly. Finally, there is clear variability in implementation
success among teams attending the training, ranging from 0
to 5 new services implemented. The remainder of the results
explore reported implementation strategies, barriers and facil-
itators, and their potential relationship to implementation
success.
Table 2 displays a summary of the strategies, barriers, and
facilitators reported by each clinic. On average, high and
moderate change teams reported 5.6 strategies, while low
change teams reported 3 strategies and no change teams re-
ported 2 strategies. The most frequently cited strategies used to
implement change included the local team established for the
training program holding team meetings, meeting with addi-
tional SUD clinic staff, meeting with hepatitis clinic staff, or
meeting with representatives from administration. With the
exception of holding training program team meetings, these
strategies were employed by most teams regardless of degree
of change. Additional strategies were utilized predominantly
by high and moderate change teams.
On average, high andmoderate change teams reported 3.7
barriers, while low change teams reported 2 barriers, and no
change teams reported 5 barriers. The most frequently cited
barriers to implementing change included lack of time and
competing priorities, not enough staff, poor collaboration
with the hepatitis treatment clinicians, and patient issues that
interfered with appropriate follow-up (e.g., no-shows,
homelessness).
On average, high and moderate change teams reported 2.1
facilitators, while low change teams reported 1 facilitator and
no change teams reported 0.5 facilitator. The most frequently
cited facilitating conditions for implementing change included
a strong collaboration with the hepatitis clinic and having
interested and knowledgeable staff in the SUD clinic beyond
team members. These were reported by many teams across all
change categories. Additional facilitators were cited only by
high and moderate change teams.
CHALLENGES & FUTURE PLANS
The Minneapolis VA HCRC training program was originally
developed for hepatitis treatment clinicians to promote
evidence-based evaluation and treatment of patients with hep-
atitis C. A previous evaluation demonstrated the effectiveness
of the program in improving clinic processes and promoting
organizational change.22 For the LHI, the original structure of
the training program was retained, while the specific content
was revised to address a different population and a different
goal. Results indicate that the effectiveness of the training
model is generalizable to this new population and goal, and
that the training program is superior to receiving printed
training materials. The results also reveal substantial variabil-
ity in implementation success among the training teams.
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As the number of changes implemented increased, the
number of strategies and facilitators reported also increased.
While an inverse relationship with barriers might be expected
(e.g., more barriers reported, fewer changes implemented),
there was no consistent relationship.
Looking at facilitators, it is notable that the teams that were
more successful at implementing practice change were more
likely to endorse support from the broader system beyond the
SUD clinic (e.g., receiving additional staff to assist with im-
plementation, receiving help from other services when re-
quested, and feeling supported by the hospital administration).
This suggests that the effectiveness of the training program
could be further improved if efforts were made to solicit
support from medical center leadership.
Training teams employed a greater number of strategies,
and the types of strategies were qualitatively different. All but
one training team (also the only training team in the no change
category) held formal LHI team meetings, while none of the
comparison teams held such meetings, despite forming a team
for submission of their LHI application. In addition, training
teams were more likely to use active implementation
strategies—strategies that required effort beyond convening
meetings, such as developing and providing in-service train-
ing, developing standardized templates for notes or orders, or
establishing a data collection process to monitor progress on
goals. These findings suggest that a functional team and active
change strategies are vital ingredients for making changes in
clinic practice. Only three teams reported having any contact
with training teams from other facilities despite having access
to contact information for other teams. The impact of the
training program could have been improved by facilitating
greater interaction among teams following the training to share
successful strategies.
These findings provide preliminary support for the value of
specific components of the training program aimed at devel-
oping a functional team, educating teams in specific active
change strategies, and walking them through several steps of
the implementation process.
Limitations in the methods of data collection affect the
generalizability of these results. Implementation success was
reported by one representative from each team, who clearly
knew whether their team had been selected to attend the
training or wait-listed. This awareness may have created de-
mand characteristics encouraging the training team
Table 2 Strategies, Barriers and Facilitators Reported by Clinics
Change category High Moderate Low None
Clinic 3 7 1 12 2 4 6 9 14 5 10 13 8 11 15 16
Condition* I I I I I I I I I I W W W I W W
Strategies
Local training team meetings X X X X X X X X X X
Training team meets with other SUD staff X X X X X X X X X X
Training team meets with other hepatitis clinic staff X X X X X X X X X X
Training team meets with facility administration X X X X X X X X X
Provide in-service for SUD clinic staff X X X X X X X X X
Provide in-service for hepatitis clinic staff X X X
Contact with other preceptorship participants X X X
Collaborate with additional services
(e.g., lab, pharmacy)
X X
Create standardized templates for notes, consults or
orders
X X X
Collect baseline data to guide goal development/track
progress
X X X
Utilize materials provided by project
(e.g., protocols, educational video)
X X X X X
Barriers
Lack of time/competing priorities X X X X X X X X X X X X X
Not enough staff X X X X X X X X X
Poor collaboration with the hepatitis clinic X X X X X X X
Patient issues that interfere with appropriate follow-up
(e.g., homelessness, no-shows)
X X X X X X X
SUD clinic in physically separate location from hepatitis
clinic
X X X X
Technology issues that prevented use of training
materials
X X X
Incompatible procedures in other clinics X X X X X
Lack of support from facility administration X X X X
Lack of knowledge about hepatitis among SUD staff X X X
Lack of support from SUD clinic staff X X X
Budget constraints X X X
Facilitators
Strong collaboration with hepatitis clinic X X X X X X X
Interested and knowledgeable staff X X X X X X
Felt supported by facility and/or VHA national
administration
X X
Received help from other services (e.g., lab, pharmacy) X X X X
Gained additional staff to assist with implementation X X X X
Coaching calls X
* I = Intervention, W = Wait-List
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representatives to over-report their success. Credibility of the
reports could have been improved by gathering an indepen-
dent report from another team member or from an SUD staff
member who was not part of the training team. Also, while
implementation of a new service had to meet the minimum
standards listed in Table 2 to receive Bcredit^, it is possible that
some teams may have implemented higher-quality services
than others. Perhaps prioritizing implementation of one or two
high-quality services would have greater impact on patient
outcomes than focusing on the entire package of services.
Since patient-level outcomes were not collected, this remains
unknown. In addition, while the training teams were randomly
selected from the applicants, wait-listed teams self-selected to
complete the project evaluations. Although five of six agreed
to complete the evaluations, it is not clear how those that
agreed may have differed from the program that declined.
Finally, participating clinics were embedded in large VA med-
ical facilities. Generalizability to community SUD clinics
would require further evaluation.
In the future, it will be necessary to assess the impact of
practice change prompted by this training model on patient-
level outcomes such as screening and vaccination rates. To
date, all evaluation of the model has focused on practice
change, which is assumed to translate into improved patient-
level outcomes. It will also be necessary to evaluate the
effectiveness of this training model in areas distinct from
hepatitis care in order to establish the model as a generalizable
method to improve the quality of medical care.
TEACHING COMMENTARY
By Bruce E. Landon, MD, MBA, MSc
This paper describes and evaluates a quality improvement
program that takes the form of a discrete educational interven-
tion (the Liver Health Initiative) aimed at improving screening
and treatment for hepatitis for VA patients enrolled in sub-
stance use disorders (SUD) clinics. To understand its effec-
tiveness, the authors evaluated the first cohort of SUD centers
that completed the training module.
In this commentary, I outline the importance of including
both Bprocess^ and Boutcomes^ components in evaluations of
QI interventions, with a particular focus on understanding the
importance of knowing both whether the intervention was
successful overall and how the innovation was implemented
at various clinics.24 In addition, I comment on other design
aspects of the intervention that contribute to the usefulness of
the evaluation, including the use of mixed methods and the
reliability and validity of relying on informant interviews to
understand whether an intervention was effective.
EVALUATION DESIGN
This largely qualitative evaluation consisted primarily of tele-
phone interviews conducted with a clinic representative at 1, 3,
and 6 months asking about post-implementation success as
well as facilitators and barriers. Although used in the evalua-
tion, the calls also were part of the intervention in that theywere
used as opportunities to coach the teams in implementation of
their plans. Teams were categorized according to the extent to
which they added services, with 9 of 11 intervention teams
rated as achieving high to moderate implementation success.
MIXED METHODS RESEARCH IN IMPLEMENTATION
SCIENCE
In implementation science, it is important both to understand
the effectiveness of a particular intervention (e.g., in this case,
whether the educational program improved treatment) as well
as to understand how the outcome was achieved by under-
standing the specific changes made at clinics in order to affect
care, as well as the extent to which clinics adhered to the
recommendations of the QI intervention.
In addition, feedback on the implementation of a model can
also help inform the evolution of the model and improve it
over time. Such innovations are rarely Bfixed,^ in that there are
always ways to improve or evolve the model, or adapt it to
local circumstances through experiential learning.25 In fact,
the Institute for Health Care Improvements’ collaborative
model for achieving breakthrough improvement teaches
methods of quality improvement including plan/do/study/act
cycles, but leaves it to individual clinics to identify strategies
and tactics that might work in their own environments.26,27
Thus, evaluations can help determine what specific aspects of
the program were implemented in order to explain how an
overall result was achieved.
UNDERSTANDINGWHETHER AN INTERVENTION
WORKS
The first important step to understanding the impact of any QI
intervention is to evaluate the impact of the intervention on
patient care and outcomes. Even if the educational interven-
tion was reported as effective by participants, its ultimate
success as a quality improvement intervention will be defined
by the extent to which patients at the enrolled clinics received
the recommended screening tests and treatments.
In this case, the main results of the evaluation are based on
reports from a single informant from each clinic who reported
whether the clinic had implemented each of the recommended
practices within 6 months, but the evaluation failed to address
whether the intervention effectively improved care. This ap-
proach also raises questions about the reliability and validity
of such reports. Reliability is defined as the extent to which a
particular characteristic (in this case, of a clinic) is measured
consistently, whether, for example, as reported by different
respondents (inter-rater reliability) or by the same respondent
over time (test-retest reliability). Reports on organizational
practices from a single informant tend not to be highly reliable
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unless the respondent is reporting on basic structural charac-
teristics. For instance, in an earlier study, we found that a
single respondent could accurately report the number of phy-
sicians in a practice, but in order to obtain reliable measures of
clinic operational characteristics, more responses were re-
quired than there were members of a typical clinic.28 Thus,
relying on a single informant often can be problematic, par-
ticularly for aspects of clinical management that might not be
applied uniformly across a clinic.
Validity refers to the extent to which responses reflect what
is actually happening in the clinic. In this case, there also were
reasons to question the validity of the responses. Respondents
participating in the QI program likely would have been biased
to provide responses that conformed to the tenets of the
educational program, whereas those who were in the control
group would have been less likely to endorse these activities
simply as a result of being in the program.29,30 Thus, this level
of evidence might be suggestive of the success of the program,
but should only be considered as hypothesis-generating, and
more objective evidence would be required before concluding
that the program was effective.
The investigators might consider alternative approaches in
order to understand more definitively whether the program
worked. A common approach that would allow for such
inferences would be to collect actual clinical data, and there
are several potential study designs that would allow for this
type of effectiveness evaluation. In many QI interventions,
clinics are instructed to create registries and to record the
results of tests and interventions. In this case, the intervention
is aimed at new enrollees to the clinic (which ranges from
approximately 5 to 50 new patients per month across clinics).
Thus, it would not be particularly burdensome for clinics to
create a registry to track the actual outcomes for each of the
newly enrolled patients. A limitation to this approach, howev-
er, is that control clinics would not be collecting these data,
and if they were asked to as part of the study, the mere
collection of data could influence their results. In addition, if
some patients were excluded from the registries, this could
lead to inaccurate or biased results.
A better design would be to collect these data via other
means. With sufficient funding, chart reviews could be con-
ducted at both intervention and control sites. Alternatively, it
also is possible that these data could be collected
passively—in this case, through the VA health care system’s
unified electronic medical record if one could identify the
patients being seen in the clinics.31 In this case, the ultimate
goal of this program is to perform laboratory tests and vacci-
nate patients as needed and to make sure that those who screen
positive are reliably referred into care, all of which can be
ascertained through the EMR. Either of these approaches
would provide the strongest evidence of the success of the
program. In addition, researchers also could passively access
other potential SUD treatment sites to expand the candidate
pool of control centers.
Text Box 1. Teaching Points for Quality Improvement
Evaluations
UNDERSTANDING THE HOW OF AN INTERVENTION
As opposed to the controlled settings of clinical trials, most QI
interventions are implemented in the Bmessy^ world of actual
clinical practice. As noted by others, QI interventions seek to
change behavior rather than create new scientific knowledge,
and learning inQI is driven by experiential learning.32Moreover,
improvement efforts are context-dependent, and both the inter-
ventions and the outcomes can be modified over time based on
feedback.33 Thus, qualitative interview techniques such as those
used in this study are well suited to learning about the nuances of
an intervention and the potential barriers and facilitators to
implementation. Thus, once it is known whether an intervention
is effective, qualitative techniques are useful for understanding
the how of the intervention—the mechanism, the specific popu-
lations, and the settings where it is most effective.
Such techniques also can inform efforts to redesign or
improve interventions. Evaluations can be used to assess the
extent to which clinics adhered to the intervention, and can
potentially identify aspects of the program that were more or
less likely to be adopted by participating clinics. For instance,
in the current study, the interviews assessed whether the clinics
addressed each of the recommended practices at 6 months.
Thus, such interviews can provide data on how well the
intervention was being implemented and aspects of the inter-
vention that seemed to work better or worse. Such information
would be useful for potentially redesigning the intervention.
In addition, qualitative interviews can be particularly effec-
tive for identifying barriers to implementation as well as
aspects of clinics that might have facilitated the intervention.
Such knowledge can be useful in propagating interventions to
other clinics, whether by informing the selection process by
focusing on clinics that lacked specific barriers or by helping
to inform changes in the program that might overcome barriers
or take advantage of facilitating factors. Issues such as the lack
of time, staffing, or attention such as seen in this study might
lead designers of interventions to require specific commit-
ments of resources from senior management, whereas chal-
lenges such as poor collaboration with the hepatitis clinic
might require active participation of health system leaders.
Qualitative interviews also can provide insight into how
particular characteristics might have influenced the success
of the implementation. In this study, participating clinics
ranged in size (including both the number of staff and number
• Quality improvement evaluations should include both Bprocess^ and
Boutcomes^ components in order to understand both whether the
intervention worked and how it worked.
• Mixed methods approaches are well suited to addressing these
questions.
• Evaluation designs should carefully consider both potential biases
related to the design and the reliability and validity of the data used in
the evaluation.
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of patients treated) as well as organizational structure, and
some of these might have been more conducive than others
to accomplishing the goals of the QI project. In particular,
receiving support, including both resources and buy-in from
the greater health system, was seen as important to the success
of individual clinics.
Thus, understanding both whether an intervention was ef-
fective and how it worked are crucially important in imple-
mentation science. Both aspects are required in order to allow
readers to understand how a particular intervention might
work in their own context and to help guide the investment
of their scarce resources.
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